Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 453 SEK 0.11% Market Closed
Market Cap: 14.3B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Net Margin
Xvivo Perfusion AB

27.2%
Current
8%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
27.2%
=
Net Income
204.3m
/
Revenue
750.6m

Net Margin Across Competitors

Country SE
Market Cap 14.3B SEK
Net Margin
27%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Net Margin
11%
Country DK
Market Cap 205.9B DKK
Net Margin
19%
Country US
Market Cap 16B USD
Net Margin
11%
Country CN
Market Cap 53.9B CNY
Net Margin
42%
Country CA
Market Cap 7B USD
Net Margin
-8%
Country UK
Market Cap 5.3B GBP
Net Margin
7%
Country CH
Market Cap 5.2B CHF
Net Margin
14%
Country US
Market Cap 5.9B USD
Net Margin
9%
Country KR
Market Cap 8T KRW
Net Margin
-472%

Profitability Report

View the profitability report to see the full profitability analysis for Xvivo Perfusion AB.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
27.2%
=
Net Income
204.3m
/
Revenue
750.6m
What is the Net Margin of Xvivo Perfusion AB?

Based on Xvivo Perfusion AB's most recent financial statements, the company has Net Margin of 27.2%.